摘要
目的探讨丹参酮、多巴酚丁胺联合低分子肝素钙治疗肺心病心力衰竭的疗效。方法将180例肺心病心力衰竭患者随机分为观察组和对照组,各90例。所有患者均抗心力衰竭治疗,对照组给予低分子肝素钙,观察组在此基础上加用丹参酮和多巴酚丁胺。结果观察组总有效率为88.9%,对照组为73.3%,两组疗效比较,差异有统计学意义(P<0.05);两组治疗后心功能指标和血流动力学指标均显著改善,观察组显著优于对照组,差异有统计学意义(P<0.05)。结论丹参酮、多巴酚丁胺和低分子肝素钙联合治疗肺心病心力衰竭,能显著改善血流动力学和心功能,显著提高疗效,值得在临床推广应用。
Objective To investigate the clinical curative effect of tanshinone,dobutamine and Low Molecular Heparin in treatment of pulmonary heart disease with heart failure.Methods 180 case of pulmonary heart disease with heart failure were retrospective analyzed;all those patients were random divided into two groups（the observation group,the control group）,who were given a general anti-heart failure treatment.The observation group was given an extra tanshinone,dobutamine and Low Molecular Heparin treatment on the base of conventionality.Results In observation group,the total effective rate was 88.9%,73.3% in the control group,two groups,the difference was statistically significant（P0.05）;two groups after treatment of heart function index and hemodynamic index were significantly improved,the observation group was better than the control group,the difference was statistically significant（P0.05）.Conclusion The unite application of tanshinone,dobutamine and low molecular weight heparin can significantly improve clinical curative effect in treatment of pulmonary heart disease with heart failure,which is worthy of clinical application and promotion.
出处
《实用心脑肺血管病杂志》
2013年第1期96-97,共2页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词
丹参酮
多巴酚丁胺
肝素
低分子量
肺心病
心力衰竭
治疗结果
Tanshinone
Dobutamine
Heparin
low-molecular-weight
Pulmonary heart disease
Heart failure
Treatment outcome
